In vivo Characterization of Amorphous Silicon Carbide As a Biomaterial for Chronic Neural Interfaces by Gretchen L. Knaack et al.
ORIGINAL RESEARCH
published: 28 June 2016
doi: 10.3389/fnins.2016.00301
Frontiers in Neuroscience | www.frontiersin.org 1 June 2016 | Volume 10 | Article 301
Edited by:
Weien Yuan,
Shanghai JiaoTong University, China
Reviewed by:
Yingjie Sun,
Harvard University, USA
Robert W. Komorowski,
Massachusetts Institute of
Technology, USA
*Correspondence:
Joseph J. Pancrazio
joseph.pancrazio@utdallas.edu
Specialty section:
This article was submitted to
Neural Technology,
a section of the journal
Frontiers in Neuroscience
Received: 23 April 2016
Accepted: 15 June 2016
Published: 28 June 2016
Citation:
Knaack GL, McHail DG, Borda G,
Koo B, Peixoto N, Cogan SF,
Dumas TC and Pancrazio JJ (2016) In
vivo Characterization of Amorphous
Silicon Carbide As a Biomaterial for
Chronic Neural Interfaces.
Front. Neurosci. 10:301.
doi: 10.3389/fnins.2016.00301
In vivo Characterization of
Amorphous Silicon Carbide As a
Biomaterial for Chronic Neural
Interfaces
Gretchen L. Knaack 1, 2, Daniel G. McHail 1, German Borda 3, Beomseo Koo 3,
Nathalia Peixoto 4, Stuart F. Cogan 5, Theodore C. Dumas 1 and Joseph J. Pancrazio 2, 5*
1Department of Molecular Neuroscience, Krasnow Institute for Advanced Study, George Mason University, Fairfax, VA, USA,
2Quantitative Scientific Solutions, Arlington, VA, USA, 3Department of Bioengineering, George Mason University, Fairfax, VA,
USA, 4 Electrical and Computer Engineering Department, George Mason University, Fairfax, VA, USA, 5Department of
Bioengineering, University of Texas at Dallas, Richardson, TX, USA
Implantable microelectrode arrays (MEAs) offer clinical promise for prosthetic devices
by enabling restoration of communication and control of artificial limbs. While
proof-of-concept recordings from MEAs have been promising, work in animal models
demonstrates that the obtained signals degrade over time. Both material robustness
and tissue response are acknowledged to have a role in device lifetime. Amorphous
Silicon carbide (a-SiC), a robust material that is corrosion resistant, has emerged as
an alternative encapsulation layer for implantable devices. We systematically examined
the impact of a-SiC coating on Si probes by immunohistochemical characterization of
key markers implicated in tissue-device response. After implantation, we performed
device capture immunohistochemical labeling of neurons, astrocytes, and activated
microglia/macrophages after 4 and 8 weeks of implantation. Neuron loss and microglia
activation were similar between Si and a-SiC coated probes, while tissue implanted with
a-SiC displayed a reduction in astrocytes adjacent to the probe. These results suggest
that a-SiC has a similar biocompatibility profile as Si, and may be suitable for implantable
MEA applications as a hermetic coating to prevent material degradation.
Keywords: amorphous silicon carbide, neuroprosthetic device, neural electrode, foreign body response,
neuroinflammatory response, in vivo models
INTRODUCTION
Implantable microelectrode arrays (MEAs) offer clinical potential as a neural interface for
prosthetic devices by enabling restoration of communication and control of artificial limbs
(Hochberg et al., 2006; Velliste et al., 2008). A variety of materials have been used to develop
MEA technology including silicon, polymers, and metal (Kozai et al., 2012b; Prasad et al., 2012;
Barrese et al., 2013). While proof-of-concept recordings from MEAs have been promising, work
in animal models demonstrates that the obtained neural signals degrade over time (Rousche and
Normann, 1998; Williams et al., 1999) and the reliability of this approach has been the subject of
recent attention. Furthermore, there is significant variability in the chronic electrode performance
timeline across research groups, animal models, and even within the same implant (Polikov et al.,
2005).
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Currently, implantable MEAs penetrate the blood brain
barrier and cause shearing of vasculature, disturbances to
the extracellular matrix, glia, and neurons, resulting in a
neuroinflammatory response (Polikov et al., 2005; Bjornsson
et al., 2006). The neuroinflammatory response is characterized
by immediate activation of macrophages and microglia, which
causes extension of processes toward the site (Polikov et al., 2005;
Stice and Muthuswamy, 2009; Winslow and Tresco, 2010; Kozai
et al., 2012a; Potter et al., 2012; Woolley et al., 2013). Astrocytes
are also recruited, as indicated by upregulation of glial fibrillary
acidic protein (GFAP), and extension of processes toward the
implant site (Fawcett and Asher, 1999; Polikov et al., 2005; Stice
and Muthuswamy, 2009; Winslow and Tresco, 2010; Bardehle
et al., 2013). A significant loss of neurons proximal to devices
has additionally been reported by some groups (Winslow and
Tresco, 2010; Potter et al., 2012); however, the extent of this
reaction is not consistent across animals and is dependent on
the material, size (Stice et al., 2007), shape and insertion rate
of the implant (Bjornsson et al., 2006). This neuroinflammatory
response may be related to eventual device failure observed
chronically (Fawcett and Asher, 1999; Winslow and Tresco,
2010), but a clear link between the tissue and device performance
remains to be drawn (Polikov et al., 2005). One reasonmay be the
variability in surgical technique, IHC protocols and data analysis
between groups; standardized methodologies within the neural
interface field could close this knowledge gap.
Material degradation may be another factor in device failure
since several studies report structural changes of implanted
MEAs including commonly used materials like silicon (Si),
in vitro (Alexander et al., 1954) and in vivo (Prasad et al.,
2012; Barrese et al., 2013, 2016; Kane et al., 2013). A hermetic
coating of the neural interface could decrease dissolution of
materials (Cogan et al., 2003; Zorman, 2009). Recently, several
groups have explored the potential utility of silicon carbide
(SiC) as an encapsulation layer for implantable neural devices
(Cogan et al., 2003; Hsu et al., 2007; Frewin et al., 2011).
SiC is a robust material that withstands high temperatures
and adverse chemical conditions (Zorman, 2009), although
additional material properties are dependent on the form of SiC
produced. One of these types, amorphous SiC (a-SiC), has the
following beneficial properties: diffusion barrier, low temperature
deposition, direct binding to Si (Zorman, 2009), slow dissolution
rate, and biocompatibility (Cogan et al., 2003; Iliescu et al.,
2008). a-SiC has already been employed as a protective coating
for orthopedic implants (Sella et al., 1993) and coronary stents
(Amon et al., 1996). Moreover, efficacy in preventing both
thrombogenic and inflammatory effects has been demonstrated
(Hamm et al., 2003). Therefore, utilizing a-SiC as a novel material
for neural interface technology could prove beneficial.
Thoroughly understanding the potential of a novel
material for implantable neural devices requires systematic
characterization of key markers implicated in the tissue-device
response at multiple time points. Therefore, the aim of this
study was to rigorously compare neuroinflammatory markers
between silicon devices coated with a-SiC and uncoated silicon
devices. To ensure consistency in the investigation, confounding
experimental factors were minimized by standardization
of device dimensions, simultaneous implantation of
experimental and control probes, and counterbalancing
hemisphere placement of experimental and control probes.
Moreover, we performed device capture (Woolley et al., 2011)
immunohistochemical labeling of neurons, astrocytes, and
activated microglia/macrophages at 4 and 8 weeks; a method
which assesses intact tissue slices without the removal of the
implant. Neuron loss and microglia activation were similar
between Si and a-SiC coated devices, while tissue implanted
with a-SiC displayed a reduction in astrocytes adjacent to the
neural interface. These results suggest that a-SiC has a similar
biocompatibility profile as Si, andmay be suitable for implantable
MEA applications as a hermetic coating to prevent material
degradation.
MATERIALS AND METHODS
Subjects
All animal procedures complied with the National Institutes
of Health Guide for Care and Use of Laboratory Animals
and were approved by the Institutional Animal Care and Use
Committee (IACUC) at George Mason University. Adult female
Long Evans rats (210–345 g) were chronically implanted with
a non-functional neural device for either 4 weeks (n = 3) or 8
weeks (n= 5).
Neural Implants
Single shank non-functional devices were inserted into the
primary motor cortex of rats. Conventional Si devices
(NeuroNexus, Ann Arbor, MI) were deposited with 0.5 µm
a-SiC using plasma-enhanced chemical vapor deposition
(PECVD). Si devices without a-SiC were also inserted as
controls. Both devices were 5 mm in length, 15 µm thick, 200
µm in width at the base and 125 µm in width at the widest part
of the shank in contact with cortical tissue. The plastic holders
of each device were glued together such that the shanks were
parallel with each other and could be inserted simultaneously.
This combined device was sterilized with ethylene oxide gas
for 24 h. The methodological approach of implanting materials
simultaneously into the same animal allowed us to control
for variability across animals, surgery time, insertion rate,
immunohistochemistry runs, and other possible confounds.
Surgery
Rats were fully anesthetized with a 5% isoflurane/oxygen mixture
at a rate of 1 L/min and maintained at 2%. Pain sensitivity
was tested by paw pinches and breathing was monitored
throughout surgery. Body temperature was maintained by a
heating pad (Braintree Scientific, Braintree, MA). Surgical tools
were sterilized with ethylene oxide gas and aseptic surgery
technique was used. Each animal underwent shaving of the fur
from between the eyes to behind the ears prior to placement in
a stereotaxic frame (Kopf instruments, Tujunga, CA). Puralube
eye ointment (PharmaDerm, Florham Park, NJ) was applied to
the eyes followed immediately by a mid-scapular subcutaneous
injection of dexamethasone (2 mg/kg; 2 mg/mL; Sparhawk
Laboratories, Lenexa, KS) and lidocaine delivery under the scalp
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(2%; Clipper Distributing Company, St. Joseph, MO). The skin
surface was disinfected with a 10% povidone iodide solution
(Qualitest Pharmaceuticals, Inc., Huntsville, AL) before cutting
a small opening with sterile scissors. The fascia was removed and
the skull cleaned with three alternations of 70% ethanol and 3%
hydrogen peroxide, finishing with an additional application of
ethanol. Compressed air was used to dry the skull in between each
application.
Drilling and probe placement were visualized through a
surgical scope (Seiler Instrument and Manufacturing Company,
St. Louis, MO). Six skull screws were placed in burr holes
drilled with a micro drill (Stoelting, Wood Dale, IL) to anchor
the skull cap. Bilateral craniotomy windows were drilled to
target the primary motor cortices (from bregma: −1.5 to + 1.5
mm anterior/posterior and ±0.5 to ±2.5 mm medial/lateral). A
small portion of dura was retracted, paying special attention to
avoid any surface vasculature. The device tips were manually
lowered to the surface of the cortex and the devices were then
inserted simultaneously at a rate of 2 mm/sec with an electronic
micropositioner (Kopf instruments, Tujunga, CA).
After implantation, the craniotomies were filled with silicone
elastomer (Kwik-Cast, World Precision Instruments, Sarasota,
FL). A layer of Loctite Prism 454 adhesive (Electron Microscopy
Science, Hatfield, PA) was also applied and cured instantly with
Loctite accelerant 7452 (Newark Element 14, Chicago, IL) to
secure the device to the skull and screws. Dental cement (Lang
Dental Manufactures, Wheeling, IL) was used to additionally
secure the screws to the skull and create a robust head cap.
Wound openings between the head cap and the surrounding
skin were closed by attaching the skin to the dental cement
using GLUture (World Precision Instruments, Sarasota, FL) and
a triple-antibiotic cream was applied. To rehydrate the animals,
3 mL of 0.9% sterile saline was given subcutaneously. Ketoprofen
(Fort Dodge Animal Health, Fort Dodge, Iowa) was administered
subcutaneously at 5 mg/kg and continued twice daily for 3 days.
Gentamicin (Clipper Distributing Company, St. Joseph,MO)was
also injected subcutaneously at 8mg/kg and continued once a day
for 1 week.
Immunohistochemistry (IHC)
Implants remained in the brain for either 4 weeks or 8 weeks.
Each implant was coded as either left or right hemisphere,
instead of material type, to blind the researchers and prevent
experimenter bias. Rats were sacrificed by exsanguination
from transcardial perfusion after anesthetizing with a 5%
isoflurane/oxygen mixture (1 L/min) until no pain response
was observed. Blood was cleared with phosphate buffered saline
(1X PBS, Fisher Scientific, Pittsburg, PA) followed by 4%
paraformaldehyde (PFA) to fix the tissue. The entire head was
placed in PFA for 48 h and then stored in PBS containing 90
mg/L sodium azide (Sigma-Aldrich, St. Louis, MO) at 4◦C until
head caps were removed (all subsequent steps with PBS contain
sodium azide).
Head caps were removed with the probes remaining in the
brain for device capture IHC (Woolley et al., 2011). Briefly, dental
cement and adhesive were removed by first cutting with a Dremel
cutting wheel followed by drilling with a micro drill bit. The
probes were separated at the base from the Si elastomer using
microscissors. The elastomer was then removed using forceps
and the skull was carefully detached from the brain leaving the
probes intact. All of these steps were performed under a surgical
scope. Brains containing the probes were then placed in fresh PBS
with sodium azide and stored at 4◦C until slicing.
Brains were sliced in the sagittal plane (200–250 µm) with
a vibratome, such that one slice contained the entire probe.
Free-floating sections were placed in a single well of a 24-well
culture plate containing PBS. All slices were labeled with primary
antibodies for neurons (chicken anti-NeuN, Millipore, Billerica,
MA), reactive microglia/macrophages (monoclonal mouse anti-
ED1 CD68, Millipore, Billerica, MA), glial fibrillary acidic
protein of activated astrocytes (rabbit anti-GFAP, Dako North
America Inc., Carpinteria, CA), and cellular nuclei (DAPI, Life
Technologies, Grand Island, NY).
Auto fluorescence was quenched two times with 6 mg/mL
sodium borohydrate (Sigma-Aldrich) for 15 min each, followed
by three washes with PBS for 5 min each. Sections were incubated
in blocking buffer containing 4% normal goat serum (Life
Technologies) and 0.3% Triton-X 100 (Sigma-Aldrich) in PBS
for 1 h followed by three rapid washes with PBS. Slices were
additionally blocked with Image-iT FX (Life Technologies) for
30 min followed by three rapid washes in PBS. Slices were then
incubated overnight at 4◦C in primary antibody solution (CD68
1:1000, GFAP 1:500, NeuN 1:500 diluted in blocking buffer
containing 4% normal goat serum and 0.1% Triton-X 100 in
PBS). Following four washes with PBS for 15min each, slices were
incubated for 1 h at room temperature in fluorophore-conjugated
secondary antibodies (goat anti-chicken 647, goat anti-mouse
546, goat anti-rabbit 488, 1:1000, Life Technologies) and DAPI
(0.6µm) diluted in the same blocking buffer used for the primary
antibodies. To ensure homogenous penetration of all solutions
slices were flipped half way through each step. Lastly, slices were
washed three times in PBS for 15 min each and mounted on
glass microscope slides using Fluoromount-G (Southern Biotech,
Birmingham, AL).
Imaging
All slices were imaged using a confocal microscope at 20x
objective (Nikon D-eclipse C1si; Nikon Instruments, Melville,
NY). Laser intensity and gain were held constant for each label
across all slices. To obtain a broader field of view without losing
resolution, each complete image contained 20 individual 20x
images stitched together using Photoshop (Adobe Systems Inc.,
San Jose, CA). To control for naturally occurring variance in
cell type density between cortical layers, complete images were
cropped into individual layers according to Kandel et al. (2000).
For some slices, the implanted devices extended past the cortex
and into the white matter. These images were cropped at the end
of layer six and the white matter was not analyzed.
Data Analysis
Cropped images were analyzed and normalized within each
cortical layer. Fluorescence intensity was measured for NeuN,
GFAP, CD68, and DAPI using MINUTE (Potter et al., 2012), a
custom-written MATLAB program (Math Works, Natick, MA).
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An ellipse was used to outline the edge of the device within each
cropped image (Figure 1).
Intensity values were determined as a function of distance
from the device edges every 10 µm out to a final distance of 500
µm. In order to combine fluorescence intensity, at each distance,
across cortical layers, values were normalized to background
within each layer as defined as the mean intensity value 400–500
µm from the probe edge, and then averaged across cortical layers
to obtain a mean, normalized fluorescence intensity every 10 µm
for each tissue slice. Outliers were removed if they were two
standard deviations from the mean. For each label, differences in
fluorescence intensity were compared using a three-way mixed
ANOVA with Material (a-SiC, Si) and Time (4 weeks, 8 weeks)
as between-subjects factors and Distance (0–100 µm) as a within
subjects factor. A Huynh-Feldt correction was used if sphericity
was violated and significance was determined as p < 0.05. Any
significant main or interaction effects were followed up with
planned contrasts due to a priori hypotheses where all distances
were compared to baseline as defined as 100 µm from the
device edge, consistent with prior work (McConnell et al., 2009;
Winslow and Tresco, 2010; Azemi et al., 2011).
Additionally, area under the curve (AUC) for NeuN, GFAP,
and CD68 was calculated for fluorescence intensity for 0–100
µm from the device edge, where the maximal changes were most
often noted. Pearson correlations between the three targets were
then conducted for 4 and 8 week time points to gain insight into
the relationship between the main cell types involved in the tissue
response to implanted cortical devices.
All analyses were performed using SPSS (IBM, Armonk, NY).
Data are presented as mean± standard error of the mean (SEM)
unless otherwise stated.
RESULTS
Device capture IHC was used to label neurons (NeuN), reactive
astrocytes (GFAP), and activated microglia (CD68) as a function
of distance from the device edge for cortical tissue implanted with
Si and a-SiC coated devices for either 4 or 8 weeks. No primary
antibody controls indicated that IHC worked with minimal non-
specific binding (Figure 2).
NeuN Labeling of Neurons
NeuN labeling displayed a decrease in intensity near implanted
devices; however, there appeared to be a recovery in NeuN
intensity with time of implant (Figure 3), regardless of whether
or not the probe was coated with a-SiC. A three-way mixed
ANOVA of NeuN revealed that there was a significant main effect
of distance [F(5.077, 55.85) = 5.67, p < 0.001], indicating that there
was less NeuN intensity proximal to devices and this observation
was independent of implanted material or time point. Planned
contrasts determined that the reduction in NeuN labeling was
located 0–30 µm from the device edge compared to 100 µm
away (Figure 4A). Mean NeuN intensity from 0 to 30 µm was
86% of the intensity measured at distal locations (100 µm) from
the device edge for both experimental and control probes. There
was also a significant main effect of time on NeuN fluorescence
intensity [F(1, 11) = 6.85, p < 0.05]. Tissue implanted for 8 weeks
had 30% more NeuN labeling compared to tissue implanted
for 4 weeks regardless of material or distance from the device
(Figure 4B). There was no main effect of material or interaction
effects between material, distance, or time on NeuN fluorescence
intensity. These data suggest that a-SiC coated devices did not
differ from uncoated Si devices with respect to the density of
proximal neurons.
GFAP Labeling of Astrocytes
In contrast to what we observed with NeuN, an increase in GFAP
labeling near each device type was visually apparent, but the
level of increase appeared to be material and time dependent
(Figure 5). A three-waymixed ANOVAof GFAP determined that
there was a significant main effect of distance [F(4.03, 48.36) =
3.69, p < 0.01], such that there was more intense GFAP signal
FIGURE 1 | Illustration of the analysis method. Complete images were cropped into individual cortical layers to control for naturally occurring variance in cellular
density. An ellipse was used to outline the device edges in each cropped image and fluorescence intensity was calculated every 10 µm as a function of distance from
the device edge. The asterisks are part of the graphical interface and used to change the size and shape of the ellipse to fit the device edge.
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FIGURE 2 | Representative images from device capture IHC for cortical
tissue compared to no primary antibody controls. NeuN was used to
label neurons (A), GFAP labeled activated astrocytes (C), and CD68 labeled
reactive microglia/macrophages (E). IHC worked with minimal non-specific
binding (B,D,F).
near the device edge regardless of implanted material or time
of implant. Planned contrasts indicated that the enhanced GFAP
labeling was specifically 0–30 µm from the device, with a mean
intensity value 13% higher overall, compared to 100 µm away
(Figure 6A). There was an interaction effect between distance
and material [F(4.03, 48.36) = 2.71, p < 0.05] where the intensity of
GFAP labeling proximal to Si devices was 31% greater, compared
to GFAP labeling proximal to a-SiC devices. Planned contrasts
specified that the difference detected between materials was
located within 0–10 µm from the device edge (Figure 6A).
There was also an interaction effect between distance and time
of implant [F(4.03, 48.36) = 2.56, p < 0.05], indicating that the
intensity of GFAP labeling decreased with distance from the
device differently depending on the time of implant. Planned
contrasts determined that tissue implanted for 8 weeks had 58%
more GFAP labeling within 0–10 µm than tissue implanted for
4 weeks (Figure 6A) and this effect was independent of material
FIGURE 3 | Representative images labeling neurons (NeuN) in cortical
tissue implanted with Si (A,C) and a-SiC (B,D) for 4 (A,B) and 8 weeks
(C,D). There was less NeuN intensity near implanted devices, but an overall
increase in labeling from 4 to 8 weeks.
type. Lastly, there was a main effect of time on GFAP intensity
[F(1, 12) = 6.71, p < 0.05], such that tissue implanted for 8
weeks had 34% more labeling in general than tissue implanted
for 4 weeks, regardless of material or distance from the device
(Figure 6B). There was no main effect of material on GFAP
intensity. These data jointly suggest that although increased
astrocyte recruitment was observed proximal to all devices, there
appears to be a reduced astrocyte response directly adjacent to
devices coated with a-SiC.
CD68 Labeling of Activated
Microglia/Macrophages
Similar to our GFAP findings, enhanced CD68 labeling was
observed near both uncoated and a-SiC coated implanted
Frontiers in Neuroscience | www.frontiersin.org 5 June 2016 | Volume 10 | Article 301
Knaack et al. a-SiC for Chronic Neural Interfaces
FIGURE 4 | Normalized NeuN fluorescence intensity as a function of
distance from the device edge for tissue implanted with Si (red) and
a-SiC (blue) probes for either 4 (dotted) or 8 weeks (solid). There was a
significant effect of distance such that tissue 0–30 µm had significantly less
NeuN labeling compared to tissue 100 µm away, regardless of material or time
of implant (A). There was also a main effect of time on NeuN fluorescence
intensity. Tissue implanted for 8 weeks had more neurons overall compared to
tissue implanted for 4 weeks regardless of material (B). Data are mean ± SEM,
*denotes p < 0.05.
devices, but the level of increase was dependent on the duration
of implantation (Figure 7). A three-way mixed ANOVA of
CD68 determined that there was a significant main effect of
distance [F(2.66, 31.97) = 14.22, p < 0.001], indicating that CD68
fluorescence intensity was greater near the probe edge regardless
of material or duration of implant. Planned contrasts denoted
that the increase in CD68 signal spanned from 0 to 80 µm from
the probe, with a 36% higher mean intensity value compared to
100 µm away (Figure 8A), and this effect was independent of
material. There was also an interaction effect between distance
and time of implant [F(2.66, 31.97) = 5.05, p < 0.01]. Planned
contrasts revealed that the difference in CD68 intensity between
durations of implant was confined to 0–10 µm from the probe,
where tissue implanted for 8 weeks had 76% more fluorescence
than tissue implanted for 4 weeks (Figure 8A), regardless of
device coating. There was no main effect of material or time
FIGURE 5 | Representative images labeling astrocytes (GFAP) in
cortical tissue implanted with Si (A,C) and a-SiC (B,D) for 4 (A,B) and 8
weeks (C,D). There was a visibly apparent increase in GFAP intensity closer to
implanted devices and this enhancement was larger for tissue implanted with
Si compared to tissue implanted with a-SiC. Additionally, there was an overall
increase in GFAP from 4 to 8 weeks, regardless of whether the probe was
coated with a-SiC.
on CD68 fluorescence intensity (Figure 8B) or an interaction
effect between material and distance. These data suggest that
the profile of activated microglia/macrophages is similar between
uncoated Si and a-SiC coated devices. Interestingly, we detected a
significant negative correlation between CD68 and NeuN at the 4
week time point [r =−0.92, p(one-tailed) < 0.01], a relationship
which was not apparent at the 8 week time point. Likewise, there
was a significant negative correlation between CD68 and GFAP at
4 weeks [r=−0.79, p(one-tailed)< 0.05] which also dissipated at
8 weeks. These data jointly suggest that as the density of reactive
microglia/macrophages increases, the density of both neurons
and astrocytes decreases.
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FIGURE 6 | Normalized GFAP fluorescence intensity as a function of
distance from the device edge for tissue implanted with Si (red) and
a-SiC (blue) probes for either 4 (dotted) or 8 weeks (solid). There was a
significant effect of distance such that tissue 0–30 µm from the device edge
had significantly more GFAP labeling compared to tissue 100 µm away,
regardless of material or time of implant (A). There was an interaction effect
between distance and material where tissue implanted with Si devices had
more GFAP labeling within 0–10 µm than tissue implanted with a-SiC devices
(A). There was also an interaction effect between distance and time of implant
such that tissue implanted for 8 weeks had more GFAP labeling within 0–10
µm than tissue implanted for 4 weeks (A). There was a significant effect of
time of implant where tissue implanted for 8 weeks had higher overall GFAP
intensity than tissue implanted for 4 weeks regardless of material (B). Data are
mean ± SEM, *denotes p < 0.05.
DAPI Labeling of Cellular Nuclei
In line with our GFAP and CD68 results, DAPI labeling exhibited
an augmented signal near uncoated Si and a-SiC coated devices,
the extent of which was implant duration dependent (Figure 9).
A three-way mixed ANOVA of DAPI intensity denoted that
there was a significant main effect of distance [F(6.87, 82.38) =
3.08, p < 0.05]. Planned contrasts indicated that the increased
DAPI labeling was specifically 30 µm from the device, compared
to 100 µm (Figure 10A), regardless of material. There was
also an interaction effect between distance and time of implant
[F(6.87, 82.38) = 2.43, p < 0.05]. Planned contrasts indicated that
FIGURE 7 | Representative images labeling reactive
microglia/macrophages (CD68) in cortical tissue implanted with Si
(A,C) and a-SiC (B,D) for 4 (A,B) and 8 weeks (C,D). There was an
increase in CD68 intensity proximal to implanted devices and this
magnification was larger for tissue implanted for 8 weeks compared to tissue
implanted for 4 weeks, regardless of probe material.
tissue implanted for 8 weeks had 11% more DAPI labeling
within 0–40 µm than tissue implanted for 4 weeks (Figure 10A)
and this finding was independent of coating. There was no
main effect of material or time on DAPI fluorescence intensity
(Figure 10B) or an interaction effect between material and
distance. Interestingly, there were DAPI labeled cells that did
not co-localize with any other label. These cells were visibly
apparent in all groups and were always located next to the device
(Figure 11). These data indicate that the overall cell density
did not differ between uncoated Si probes and a-SiC coated
probes, but also suggest that there may be another cell type of
interest.
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FIGURE 8 | Normalized CD68 fluorescence intensity as a function of
distance from the device edge for tissue implanted with Si (red) and
a-SiC (blue) probes for either 4 (dotted) or 8 weeks (solid). There was a
significant effect of distance such that tissue 0–80 µm from the probe edge
had more CD68 labeling compared to tissue 100 µm away, regardless of
material or time of implant (A). There was also a significant interaction effect
between distance and time of implant where tissue implanted for 8 weeks had
higher CD68 intensity within 0–10 µm than tissue implanted for 4 weeks (A).
There was no overall effect of material (B). Data are mean ± SEM, **denotes p
< 0.01.
DISCUSSION
Using fluorescence based immunohistochemistry, we have
systematically examined the neuroinflammatory response
between uncoated and a-SiC-coated implantable devices. Our
results indicate that a-SiC coated devices exhibit a similar
overall profile as control devices, may offer a reduction in the
inflammatory response of astrocytes within 10 µm of the device
edge, and should be further investigated as a possible hermetic
coating for neural implants.
To assess the effects of chronic implants on neuronal density,
NeuN intensity was calculated as a function of distance from
the edge of the implant. Similar NeuN intensity was observed
between tissue implanted with a-SiC coated devices and tissue
implanted with Si. This finding is in line with another report
FIGURE 9 | Representative images labeling cellular nuclei (DAPI) in
cortical tissue implanted with Si (A,C) and a-SiC (B,D) for 4 (A,B) and 8
weeks (C,D). There was an increase in DAPI intensity near implanted devices
and this amplification was larger for tissue implanted for 8 weeks compared to
tissue implanted for 4 weeks, regardless of whether the probe was coated
with a-SiC.
of comparable neuronal density between a-SiC coated devices
and controls implanted into the parietal cortex of rabbits (Cogan
et al., 2003). Overall, there was less neuronal density within
the first 30 µm of the implant, but NeuN labeling returned to
baseline at further distances. The decrease in labeling proximal
to the devices is consistent with the literature (Biran et al.,
2005; McConnell et al., 2009; Winslow and Tresco, 2010; Potter
et al., 2012) and may result from the formation of the glial
scar encapsulating the device, from neuronal death caused
during insertion, or from unhealthy neurons not expressing
NeuN. This finding occurred for both materials and time
points and parallels previous reports of unaffected neuronal
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FIGURE 10 | Normalized DAPI fluorescence intensity as a function of
distance from the device edge for tissue implanted with Si (red) and
a-SiC (blue) probes for either 4 (dotted) or 8 weeks (solid). There was a
significant effect of distance such that tissue 30 µm from device edge had
more DAPI labeling compared to 100 µm away, regardless of material or time
of implant (A). There was also a significant interaction effect between distance
and time of implant where tissue implanted for 8 weeks had higher DAPI
intensity within 0–40 µm than tissue implanted for 4 weeks (A). There was no
overall effect of material (B). Data are mean ± SEM, *denotes p < 0.05.
density 100 µm from a-SiC coated implants in Cogan et al.
(2003). Interestingly, there was an overall increase in neuronal
density for tissue implanted for 8 weeks compared to tissue
implanted for 4 weeks and this result was independent of
material. The detection of NeuN recover over time is consistent
with previous findings (Nguyen et al., 2014), but does differ
from one report (Potter et al., 2012); however, there were
methodological differences in the preparation of the tissue, which
may create differences in measurements proximal to the device.
Characteristic differences have been noted for acute and chronic
stages of the neuroinflammatory response (Turner et al., 1999;
Szarowski et al., 2003; McConnell et al., 2009; Nguyen et al.,
2014) and these data suggest that NeuN recovery is one aspect.
Since the loss of NeuN was more significant at 4 weeks, astrocyte
recruitment was higher at 8 weeks, and increased NeuN was also
detected at 8 weeks, it is unlikely that the neuronal loss proximal
FIGURE 11 | Representative images from device capture IHC for
cortical tissue implanted with Si (A,C) and a-SiC (B,D) for 4 (A,B) and 8
weeks (C,D). Neurons (NeuN) are yellow, activated astrocytes (GFAP) are
green, reactive microglia/macrophages (CD68) are red, and cellular nuclei
(DAPI) are blue. There was an increase of all labels for tissue implanted for 8
weeks compared to tissue implanted for 4 weeks. Interestingly, there were
DAPI labeled cells that did not co-localize with any other label. Representative
cells indicated by white arrows. These cells were visible in all groups and were
always located next to the device.
to implanted devices is directly caused by the formation of the
glial scar and is more likely due to insertion or unhealthy neurons
not expressing NeuN.
Markers of the neuroinflammatory response were also labeled
and quantified. In contrast with NeuN, tissue implanted with
a-SiC coated devices had less GFAP intensity within 0–10
µm, than tissue implanted with Si devices, suggesting that
a-SiC may attenuate astrocyte reactivity in tissue closest to
the device. For all groups, there was more GFAP labeling
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proximal to devices compared to further distances, which is
consistent with the glial encapsulation as previously shown
(Turner et al., 1999; Polikov et al., 2005; McConnell et al.,
2009; Winslow and Tresco, 2010; Potter et al., 2012; Nguyen
et al., 2014). Additionally, there was increased GFAP labeling
that extended more distal in tissue implanted for 8 weeks
compared to tissue implanted for 4 weeks. Jointly, these data
suggest that the astrocyte reaction is more intense adjacent
to the device and stretches further in tissue implanted for 8
weeks. This is in line with previous studies that also found
increased GFAP after 8 weeks of implantation and characterized
it as a more compact sheath (Turner et al., 1999; Szarowski
et al., 2003; McConnell et al., 2009; Nguyen et al., 2014). In
contrast, one group detected less GFAP at 8 weeks (Potter
et al., 2012) and another group detected no difference in
GFAP between 4 weeks and later time points (Winslow and
Tresco, 2010). These discrepancies may again be attributed to
methodological differences including removal of the device from
the tissue.
Similar to NeuN, CD68 labeling was consistent between tissue
implanted with a-SiC coated devices and control tissue and
suggests a comparable reactive microglia/macrophage response.
In line with GFAP results, there was enhanced CD68 labeling
proximal to all devices and the level of increase differed between
lengths of implant. Increased reactive microglia/macrophages
near devices is supported by previous studies (Biran et al., 2005;
Polikov et al., 2005; McConnell et al., 2009; Winslow and Tresco,
2010; Woolley et al., 2011; Nguyen et al., 2014) and results from
the inflammatory response. We additionally detected enhanced
CD68 labeling at 8 weeks compared to 4 weeks, which is
consistent with one other group (McConnell et al., 2009). In
contrast, a decrease from 4 to 8 weeks (Potter et al., 2012) and no
statistical differences between time points (Winslow and Tresco,
2010) has also been reported. As with the other labels, variance
across the literature may result from methodological differences.
There was also an increase in DAPI labeling near devices
and this enlarged signal was dependent on the time of implant,
which parallels GFAP and CD68, but contrasts with NeuN.
Interestingly, when images of all cellular markers were examined,
it was noted that there were numerous DAPI labeled cells that
did not co-localize with NeuN, GFAP, or CD68. These cells
were visibly apparent in all groups and were always located
next to the device. In these regions, there was a much larger
loss of NeuN and more intense CD68 labeling. Since we only
labeled reactive microglia/macrophages it is possible that these
cells could be resting/ramified microglia (Polikov et al., 2005) or
M2-type macrophages (Kigerl et al., 2009). However, the pattern
with CD68 and NeuN implies a proinflammatory cell type. A
similar observation was reported in Woolley et al. (2013) after
4 weeks of implantation and these cells were presumed to be
meningeal fibroblasts due to vimentin labeling. Other groups
have also detected connective tissue and the presence of the
extracellular matrix in the glial scar surrounding transcranial
devices (Stensaas and Stensaas, 1976; Liu et al., 1999; Kim
et al., 2004). However, this phenomenon was only observed in
the superficial layers of the cortex (Woolley et al., 2013), but
in the current study the unidentified cells were located in all
cortical layers. Numerous other cell types have been linked to the
neuroinflammatory response and could be possibilities including
monocytes, mast cells, pericytes, T-cells, B-cells, and lymphocytes
(Ransohoff and Engelhardt, 2012; Skaper et al., 2012; Jansson
et al., 2014). Future research should investigate the identity of this
cell type(s) and characterize its role in the neuroinflammatory
response to cortical implants.
Since tissue implanted with a-SiC coated devices did not
statistically differ in NeuN, CD68, and DAPI labeling from
tissue implanted with standard Si devices, a-SiC is no less
biocompatible than Si for in vivo use with chronic neural
implants. This is in line with other in vivo studies which
detected no significant difference between a-SiC coated samples
and controls for the neuroinflammatory response in the
parietal cortex and the subcutaneous inflammatory response
(Cogan et al., 2003). a-SiC coatings have also been evaluated
as biocompatible for use with coronary stents (Bertrand
et al., 1998) and orthopedic implants (Sella et al., 1993).
Furthermore, we present data showing that the addition of a-
SiC significantly reduced GFAP labeling adjacent to the devices,
which suggests that a-SiCmay reduce the astrocyte component of
the neuroinflammatory response. The neuroinflammatory data
presented here, paired with the known material properties of
a-SiC, jointly suggest that a-SiC should be further investigated
as a hermetic coating to prevent material degradation of neural
implants.
Given the inconsistencies in the literature regarding
the characterization of the neuroinflammatory response to
implantable devices over time, the neural interface field would
benefit from standardization of experimental methods so that
a better understanding of the biology can permit optimization
of the technology. Removal of the device prior to assessment,
likely eliminates the tissue most influenced by the implant.
Most of the significant cell changes detected in this study were
only within 0–80 µm from the device edge and may not have
been detected if the devices were removed. Although, the device
capture technique has been implemented before, few groups
have adopted this technique and the current study expanded this
method by comparing between structurally defined cortical layers
and not arbitrary cortical depth. This permitted for the control of
naturally occurring differences in cell density and only compare
changes induced by the implanted devices. Furthermore, by
leaving the device intact in the tissue, the current work was
able to identify an unknown cell population located on and
directly next to the devices that seems to be specifically related
to the biological response of the host to biomaterials. Lastly,
these experimental methodologies facilitated the detection of
statistically significant relationships between neurons, astrocytes,
and activated microglia/macrophages in response to the devices
and evaluate how these associations changed with duration of
implant, relationships which have not been reported previously.
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